PembrolizumabCentral nervous system lymphoma: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1778卷 / 1期

关键词：

D O I：

10.1007/s40278-019-71169-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：366 / 366

相关论文

共 50 条

[1] NatalizumabCentral nervous system lymphoma: case report
Reactions Weekly, 2017, 1676 (1) : 216 - 216
[2] NatalizumabCentral nervous system lymphoma: case report
Reactions Weekly, 2018, 1711 (1) : 215 - 215
[3] CiclosporinPrimary central nervous system lymphoma: case report
Reactions Weekly, 2020, 1800 (1) : 96 - 96
[4] TacrolimusPrimary central nervous system lymphoma: case report
Reactions Weekly, 2020, 1825 (1) : 194 - 194
[5] AzathioprinePrimary central nervous system lymphoma: case report
Reactions Weekly, 2014, 1524 (1) : 45 - 45
[6] NatalizumabPrimary central nervous system lymphoma: case report
Reactions Weekly, 2017, 1679 (1) : 133 - 133
[7] MercaptopurinePrimary central nervous system lymphoma: case report
Reactions Weekly, 2022, 1924 (1) : 280 - 280
[8] MercaptopurinePrimary central nervous system lymphoma: case report
Reactions Weekly, 2024, 2035 (1) : 272 - 272
[9] NatalizumabPrimary central nervous system lymphoma: case report
Reactions Weekly, 2009, 1281 (1) : 23 - 23
[10] A case report of primary central nervous system lymphoma
Zeng, Xu
Lu, Xiaofei
Li, Xinlong
Peng, Lilei
Chen, Ligang
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (07)

← 1 2 3 4 5 →